Asia shares eased on Wednesday on the back of weakness in China, as investors brace for a tightly contested US election that could have huge ramifications for the world’s second-largest economy, even as Beijing tries to shore up growth.MSCI’s broadest index of Asia-Pacific shares outside Japan fell 0.2% in early trade, tracking a decline in Chinese assets.US stock market ended mixed on Tuesday, with the Nasdaq scoring a record closing high as investors digested a host of corporate earnings and awaited Alphabet’s results.Here’s a table showing how US stocks performed on Tuesday:
Source: EquitymasterAt present, the BSE Sensex is trading 190 points lower and NSE Nifty is trading 66 points lower.Maruti Suzuki, Bajaj Auto and Tata Motors among the top gainers today.Cipla, Sun Pharma and Titan the other hand are among the top losers today.Broader markets are trading mixed. The BSE Midcap index is trading 0.3% lower and the BSE Smallcap index are trading 0.7% higher.Sectoral indices are trading mixed today with in auto sector and FMCG sector witnessing most buying. Meanwhile stocks in healthcare sector and oil & gas sector witnessing selling pressureThe rupee is trading at Rs 84.08 against the US dollar.In commodity markets, gold prices are trading 0.3% higher at Rs 79,455 per 10 grams today.
Adani Enterprises Q2 ResultsAdani Enterprises on Tuesday reported a 664% year-on-year (YoY) jump in its September quarter consolidated net profit at Rs 17.4 bn versus Rs 2.3 bn reported by it in the year-ago period.The company’s revenue from operations stood at Rs 226.1 bn in the reported quarter which was up 16% as compared to Rs 195.5 bn reported in the corresponding quarter of the previous financial year.The company’s board at a meeting held today also approved the Rs 20 bn fundraising plan via issue of Non-Convertible Debentures (NCD) in one or more tranches.On a sequential basis, the net profit for Q2FY25 jumped 20% versus Rs 14.5 bn reported in Q1FY25 crore.However, revenue was down 11% when compared to Rs 254.7 bn posted in the April-June quarter of FY25.AEL raised Rs 42 bn (US$ 500 m) through QIP which was subscribed with participation from international and domestic investors.AEL and its subsidiaries have raised Rs 38.7 bn ($460 million) through issuances of NCDs which were subscribed by a diversified set of investors.
Marico Q2 Results
Marico reported a 20.3% rise in consolidated net profit to Rs 4.3 bn for the quarter ending September 2024, up from Rs 3.6 bn in the same period last year.Total income increased to Rs 27.5 bn in the reporting period, up from Rs 25.1 bn a year ago. Revenue from operations rose by 7.6% to Rs 26.6 bn, compared to Rs 24.8 bn in the same quarter last year.The earnings before interest, taxes, depreciation, and amortization (EBITDA) also showed a modest increase of 5%.The FMCG firm’s quarterly expenses grew to Rs 21.9 bn, up from Rs 20.4 bn in the previous year.Marico’s quarterly business update highlighted stable sector demand, with rural markets outpacing urban areas for a third consecutive quarter. The company reported mid-single-digit volume growth in its domestic segment, showing sequential improvement. Parachute Coconut Oil achieved near mid-single-digit growth, supported by price adjustments to offset rising copra costs.Saffola Oils showed slight revenue growth as its pricing cycle turned more favourable after eight quarters. Although Value Added Hair Oils faced competitive pressures in lower-tier markets, Marico anticipates gradual demand improvement with ongoing brand investments.Foods and digital-first brands showed strong momentum, helping diversify Marico’s portfolio. The international business delivered solid low-teen growth in constant currency, with each market contributing positively.
Torrent Pharma Block DealTorrent Pharmaceuticals’ promoter, Torrent Investments Pvt. Ltd likely will sell up to 2.9% of its stake in the company through a block deal on Wednesday, 30 October. The transaction, if fully subscribed, could amount to a total deal size of Rs 30 bn.The base size of the deal is set at 2.4% of Torrent Pharma’s total equity, valued at Rs 25 bn, with an additional upsize option of 0.5%, translating to another Rs 5 bn.The promoter has set an offer floor price of Rs 3,022.71 per share for this stake sale, added sources, which would involve a 120-day lock-up period on further share sales by Torrent Investments.As of the end of the second quarter, Torrent Investments held a substantial 71.25% stake in Torrent Pharma.More By This Author:Sensex Today Ends 364 Points Higher; Nifty Above 24,450Sensex Today Trades Lower; Nifty Below 24,300; Gillette India Rallies 8%Sensex Today Ends 603 Points Higher; Nifty Above 24,300
